BRIDGEBIO PHARMA LLC / PERCEPTIVE LIFE SCIENCES / KKR & CO / Acquisition / Private / £5m

Synopsis

Equity investment by KKR and Perceptive Advisors in BridgeBio, a developer of precision medicinal therapies for the treatment of genetic pediatric diseases.

Principals

target

Bridgebio Pharma

bidder

Kkr & Co

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

latham & watkins

HQ - New York, United States

legal advisors

bidder

5553

Deals

£ 3,610.31 B

Total Value